Tolga Tanguler - 01 Feb 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: /s/ Cynthia L Anderson, Attorney-in-Fact For: Tolga Tanguler
Issuer symbol
ALNY
Transactions as of
01 Feb 2023
Net transactions value
-$1,156,692
Form type
4
Filing time
03 Feb 2023, 16:45:42 UTC
Previous filing
05 Aug 2022
Next filing
01 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $0 +5,025 $0.000000 5,025 01 Feb 2023 Direct
transaction ALNY Common Stock Sale $16,350 -73 -1.5% $223.97 4,952 02 Feb 2023 Direct F1, F2
transaction ALNY Common Stock Sale $217,445 -963 -19% $225.80 3,989 02 Feb 2023 Direct F1, F3
transaction ALNY Common Stock Sale $127,134 -561 -14% $226.62 3,428 02 Feb 2023 Direct F1, F4
transaction ALNY Common Stock Sale $910 -4 -0.12% $227.38 3,424 02 Feb 2023 Direct F1
transaction ALNY Common Stock Sale $29,143 -128 -3.7% $227.68 3,296 03 Feb 2023 Direct F5, F6
transaction ALNY Common Stock Sale $42,587 -185 -5.6% $230.20 3,111 03 Feb 2023 Direct F5, F7
transaction ALNY Common Stock Sale $200,118 -865 -28% $231.35 2,246 03 Feb 2023 Direct F5, F8
transaction ALNY Common Stock Sale $300,661 -1,293 -58% $232.53 953 03 Feb 2023 Direct F5, F9
transaction ALNY Common Stock Sale $222,344 -953 -100% $233.31 0 03 Feb 2023 Direct F5, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Options Exercise $0 -5,025 -100% $0.000000* 0 01 Feb 2023 Common Stock 5,025 $0.000000 Direct F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $223.42 to $224.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $225.21 to $226.20. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $226.23 to $227.12. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2022.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $227.63 to $228.38. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $229.87 to $230.62. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $230.90 to $231.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $231.94 to $232.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $233.02 to $233.81. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F12 On February 1, 2021 the reporting person received 10,051 restricted stock units, one-half of which vested on the first anniversary of the grant date, and one-half of which vested on the second anniversary of the grant date (February 1, 2023).